KEGG and GSEA analyses further connected poor GBM prognosis to TNF, NF-κB, and PI3K/AKT signaling pathways (Supplementary Figure S2D), with elevated activity observed in patients exhibiting high TREM1High TAM scores (Supplementary Figure S2E). The gene discussed is AKT1; the disease is glioblastoma.